Op2Lysis US patent granted

Op2Lysis US patent granted

The patent covering Op2Lysis’ O2L-001 innovation for the treatment of patients with a hemorrhagic stroke has been granted in the United States of America by the USPTO in July 2017.

A specific press release is available below

–> Click here  <–

About the author

Tiffany Le Carff administrator